Document is current
Any future updates will be listed below
-
Authors
Stork, Martin
Radocha, Jakub
Mihalyova, Jana
Spicka, Ivan
Pika, Tomas
Jungova, Alexandra
Boichuk, Ivanna
Mensikova, Klara
Straub, Jan
Sedlak, Frantisek
Minarik, Jiri
Krhovska, Petra
Novakova, Denisa
Hornakova, Michaela
Knechtova, Zdenka
Sendlerova, Nela
Dekojova, Tereza
Maisnar, Vladimir
Jelinek, Tomas
Hajek, Roman
Pour, Ludek
-
Funding
Funding for this research was provided by:
Masaryk University
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 21 July 2025
First Online: 18 August 2025
Declarations
:
: MS: Jonhson & Jonhnson: Consultancy, Other: Travel support, Honoraria for lectures JR: BMS: Consultancy, Honoraria; Sanofi: Consultancy, Honoraria; Johnson & Johnson: Consultancy, Honoraria; GSK: Consultancy; Pfizer: Consultancy, Honoraria. TJ: Janssen: Consultancy, Other: Honoraria for lectures, Research Funding; Sanofi: Other: Honoraria for lectures, Research Funding; Pfizer: Consultancy,Other: Honoraria for lectures; BristolMyers Squibb:Other:Honoraria for lectures; GlaxoSmithKline: Consultancy, Other: Honoraria for lectures; Amgen: Research Funding. IS: BMS: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees, Other: Travel Support; Amgen: Consultancy, Honoraria; Janssen-Cilag: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees, Other: Travel support; Takeda: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees; Sanofi: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees, Other: Travel Support; GSK: Consultancy, Membership on an entity’s Board of Directors or advisory committees. JM: Amgen: Consultancy, Honoraria; BMS: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees; GSK: Membership on an entity’s Board of Directors or advisory committees; Janssen: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees; Pfizer: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees; Sanofi: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees. RH: Takeda: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Honoraria, Research Funding; Amgen: Consultancy, Honoraria, Research Funding; Celgene: Consultancy, Honoraria, Research Funding; AbbVie: Consultancy; BMS: Consultancy, Honoraria, Research Funding; PharmaMar: Consultancy, Honoraria; Novartis: Consultancy, Research Funding.
